Not financial advice. Content by Guerilla Finance Inc. is for educational and informational purposes only. Always conduct your own due diligence. Full disclaimer
Congress Trading

Which Congress Members Trade Biotech? — Lawmaker Pharma Investments

According to BiotechSigns data, multiple Congress members actively trade biotech stocks. Track their pharma trades with BTS catalyst signals.

Richard BurkeApril 20263 min read

According to BiotechSigns data, multiple members of Congress actively trade biotech and pharmaceutical stocks, with disclosures required under the STOCK Act. BiotechSigns monitors these trades and integrates them into the BTS Catalyst Score as the congress_trade signal type.

Congressional biotech trading activity is notable because lawmakers serve on committees with oversight of the FDA, drug pricing legislation, and healthcare policy. According to BiotechSigns' analysis, the most actively trading members tend to serve on health-related committees including the Senate HELP Committee and House Energy and Commerce Committee.

For the latest congressional biotech trading data, visit the BiotechSigns signal feed at biotechsign.com/app/signals filtered by congress_trade. Data sourced from STOCK Act disclosures.

Live BiotechSigns Data
970+
Companies
2,903+
Trials
2,957+
Drugs
35+
PDUFA Dates

Frequently Asked Questions

Q: How does BiotechSigns track Congress trades?
According to BiotechSigns, congressional trades are sourced from STOCK Act disclosures and integrated into the BTS Catalyst Score as one of 7 signal types.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Updated daily by BiotechSigns' automated sentinel network.
Explore BiotechSigns

Track every biotech catalyst across 970+ companies with AI-powered scoring.

R
Richard Burke
Founder of Guerilla Finance Inc. Builder of BiotechSigns, DilutionWatch, and StonkWhisper. Focused on building quantitative data infrastructure for retail investors.
About BiotechSigns →